A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein

Joshua Tan(National Institute of Allergy and Infectious Diseases), Antonio Lanzavecchia(Vir Biotechnology (Switzerland))
Nature Medicine
March 19, 2018
Cited by 227


Related Papers